The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
- PMID: 15353480
- DOI: 10.1182/blood-2004-04-1596
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
Abstract
The CD28 family of receptors (CD28, cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4], inducible costimulator [ICOS], program death-1 [PD-1], and B- and T-lymphocyte attenuator [BTLA]) plays a critical role in controlling the adaptive arm of the immune response. While considerable information is available regarding CD28 and CTLA-4, the function of the more recently discovered members of the CD28 family is less well understood. This review will highlight recent findings regarding the CD28 family with special emphasis on effects the CD28 family has on immunopathology, the discovery of costimulatory antibodies with superagonist function, and the status of clinical trials using various strategies to augment or block T-cell costimulation.
Similar articles
-
The Role of the CD28 Family Receptors in T-Cell Immunomodulation.Int J Mol Sci. 2024 Jan 20;25(2):1274. doi: 10.3390/ijms25021274. Int J Mol Sci. 2024. PMID: 38279272 Free PMC article. Review.
-
Targeting T cell costimulation in autoimmune disease.Expert Opin Ther Targets. 2002 Jun;6(3):275-89. doi: 10.1517/14728222.6.3.275. Expert Opin Ther Targets. 2002. PMID: 12223069 Review.
-
The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology.Immunol Rev. 2006 Aug;212:131-48. doi: 10.1111/j.0105-2896.2006.00419.x. Immunol Rev. 2006. PMID: 16903911 Review.
-
CD28, CTLA-4 and their ligands: who does what and to whom?Immunology. 2000 Oct;101(2):169-77. doi: 10.1046/j.1365-2567.2000.00121.x. Immunology. 2000. PMID: 11012769 Free PMC article. Review. No abstract available.
-
ICOS contributes to T cell expansion in CTLA-4 deficient mice.J Immunol. 2005 Jul 1;175(1):182-8. doi: 10.4049/jimmunol.175.1.182. J Immunol. 2005. PMID: 15972646
Cited by
-
The BTNL2 G16071A gene polymorphism increases granulomatous disease susceptibility: A meta-analysis including FPRP test of 8710 participants.Medicine (Baltimore). 2016 Jul;95(30):e4325. doi: 10.1097/MD.0000000000004325. Medicine (Baltimore). 2016. PMID: 27472712 Free PMC article.
-
A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation.Am J Transplant. 2020 Jan;20(1):172-180. doi: 10.1111/ajt.15560. Epub 2019 Sep 9. Am J Transplant. 2020. PMID: 31397943 Free PMC article. Clinical Trial.
-
Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication.Mol Ther. 2010 Feb;18(2):413-20. doi: 10.1038/mt.2009.210. Epub 2009 Sep 22. Mol Ther. 2010. PMID: 19773745 Free PMC article.
-
Cutting edge: A role for inside-out signaling in TCR regulation of CD28 ligand binding.J Immunol. 2011 Dec 1;187(11):5515-9. doi: 10.4049/jimmunol.1102497. Epub 2011 Nov 7. J Immunol. 2011. PMID: 22068237 Free PMC article.
-
HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo.Mol Ther. 2020 Jul 8;28(7):1585-1599. doi: 10.1016/j.ymthe.2020.05.012. Epub 2020 May 15. Mol Ther. 2020. PMID: 32454027 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
